AD04 – modifying Alzheimer’s Disease by modulation of neuroinflammation

Carmela R Abraham, Achim Schneeberger, Agustin F Santana III, Thomas Hoffmann, Anita Fischer, Sylvie Trembleau · 2025

Read AD04 – modifying Alzheimer’s Disease by modulation of neuroinflammation by Carmela R Abraham, Achim Schneeberger, Agustin F Santana III, Thomas Hoffmann, Anita Fischer, Sylvie Trembleau (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11713042.txt.

Description

A shot additive used in vaccines for decades may slow Alzheimer's disease when given at one set dose. Carmela Abraham and five co-authors report in 2025 on that agent, called AD04, first seen as a mere control arm in a trial. In folk with mild disease it slowed the brain's memory hub from shrinking and held back mind slide. Its score on a blend of three standard scales matched or beat most drugs on the shelf.

To find how a skin shot reaches the brain, the team dosed old mice and ran a fear test. Treated old mice froze more aptly, a sign of sound recall. Their memory hubs showed shifts in fat handling and in guard cells, which turned toward eating dead cell waste. The team read the guard-cell turn as the likely path of the gain.

Catalog record

CREATORCarmela R Abraham, Achim Schneeberger, Agustin F Santana III, Thomas Hoffmann, Anita Fischer, Sylvie Trembleau
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11713042

Browse the full library · About the Tower of Babel